T1	Participants 31 47	patients of Shen
T2	Participants 316 348	in treating rheumatoid arthritis
T3	Participants 423 442	RA patients of Shen
T4	Participants 488 515	treatment group (120 cases)
T5	Participants 580 605	control group (120 cases)
T6	Participants 675 678	all
T7	Participants 1080 1111	The total effective rate was 80
T8	Participants 1113 1138	0% in the treatment group
T9	Participants 1164 1185	control group (66.7%)
T10	Participants 1229 1246	In the two groups
T11	Participants 1364 1373	patients,
T12	Participants 1499 1514	treatment group
T13	Participants 1603 1611	patients
T14	Participants 1707 1734	less in the treatment group
T15	Participants 1747 1760	control group
T16	Participants 1813 1822	symptoms,
